Search

Your search keyword '"Pham, Lan V."' showing total 37 results
Start Over Author "Pham, Lan V." Publisher american association for cancer research (aacr)
37 results on '"Pham, Lan V."'

1. Supplementary Tables from Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

Author

Xu-Monette, Ziju Y., primary, Xiao, Min, primary, Au, Qingyan, primary, Padmanabhan, Raghav, primary, Xu, Bing, primary, Hoe, Nicholas, primary, Rodríguez-Perales, Sandra, primary, Torres-Ruiz, Raul, primary, Manyam, Ganiraju C., primary, Visco, Carlo, primary, Miao, Yi, primary, Tan, Xiaohong, primary, Zhang, Hongwei, primary, Tzankov, Alexandar, primary, Wang, Jing, primary, Dybkær, Karen, primary, Tam, Wayne, primary, You, Hua, primary, Bhagat, Govind, primary, Hsi, Eric D., primary, Ponzoni, Maurilio, primary, Ferreri, Andrés J.M., primary, Møller, Michael B., primary, Piris, Miguel A., primary, van Krieken, J. Han, primary, Winter, Jane N., primary, Westin, Jason R., primary, Pham, Lan V., primary, Medeiros, L. Jeffrey, primary, Rassidakis, George Z., primary, Li, Yong, primary, Freeman, Gordon J., primary, and Young, Ken H., primary

Published
2023
Full Text
View/download PDF

2. Supplementary Table 1 from In Vitro and In Vivo Therapeutic Efficacy of Carfilzomib in Mantle Cell Lymphoma: Targeting the Immunoproteasome

Author

Zhang, Liang, primary, Pham, Lan V., primary, Newberry, Kate J., primary, Ou, Zhishuo, primary, Liang, Rong, primary, Qian, Jianfei, primary, Sun, Luhong, primary, Blonska, Marzenna, primary, You, Yun, primary, Yang, Jing, primary, Lin, Xin, primary, Rollo, Alex, primary, Tamayo, Archito T., primary, Lee, John, primary, Ford, Richard J., primary, Zhao, Xiurong, primary, Kwak, Larry W., primary, Yi, Qing, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

3. Data from Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents

Author

Deng, Manman, primary, Xu-Monette, Zijun Y., primary, Pham, Lan V., primary, Wang, Xudong, primary, Tzankov, Alexandar, primary, Fang, Xiaosheng, primary, Zhu, Feng, primary, Visco, Carlo, primary, Bhagat, Govind, primary, Dybkaer, Karen, primary, Chiu, April, primary, Tam, Wayne, primary, Zu, Youli, primary, Hsi, Eric D., primary, You, Hua, primary, Huh, Jooryung, primary, Ponzoni, Maurilio, primary, Ferreri, Andrés J.M., primary, Møller, Michael B., primary, Parsons, Benjamin M., primary, Hagemeister, Fredrick, primary, van Krieken, J. Han, primary, Piris, Miguel A., primary, Winter, Jane N., primary, Li, Yong, primary, Xu, Bing, primary, Liu, Phillip, primary, and Young, Ken H., primary

Published
2023
Full Text
View/download PDF

4. Data from Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

Author

Xu-Monette, Ziju Y., primary, Xiao, Min, primary, Au, Qingyan, primary, Padmanabhan, Raghav, primary, Xu, Bing, primary, Hoe, Nicholas, primary, Rodríguez-Perales, Sandra, primary, Torres-Ruiz, Raul, primary, Manyam, Ganiraju C., primary, Visco, Carlo, primary, Miao, Yi, primary, Tan, Xiaohong, primary, Zhang, Hongwei, primary, Tzankov, Alexandar, primary, Wang, Jing, primary, Dybkær, Karen, primary, Tam, Wayne, primary, You, Hua, primary, Bhagat, Govind, primary, Hsi, Eric D., primary, Ponzoni, Maurilio, primary, Ferreri, Andrés J.M., primary, Møller, Michael B., primary, Piris, Miguel A., primary, van Krieken, J. Han, primary, Winter, Jane N., primary, Westin, Jason R., primary, Pham, Lan V., primary, Medeiros, L. Jeffrey, primary, Rassidakis, George Z., primary, Li, Yong, primary, Freeman, Gordon J., primary, and Young, Ken H., primary

Published
2023
Full Text
View/download PDF

5. Supplementary Figure 1 from In Vitro and In Vivo Therapeutic Efficacy of Carfilzomib in Mantle Cell Lymphoma: Targeting the Immunoproteasome

Author

Zhang, Liang, primary, Pham, Lan V., primary, Newberry, Kate J., primary, Ou, Zhishuo, primary, Liang, Rong, primary, Qian, Jianfei, primary, Sun, Luhong, primary, Blonska, Marzenna, primary, You, Yun, primary, Yang, Jing, primary, Lin, Xin, primary, Rollo, Alex, primary, Tamayo, Archito T., primary, Lee, John, primary, Ford, Richard J., primary, Zhao, Xiurong, primary, Kwak, Larry W., primary, Yi, Qing, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Tables 1-5 and Supplementary Figures 1-8 from Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents

Author

Deng, Manman, primary, Xu-Monette, Zijun Y., primary, Pham, Lan V., primary, Wang, Xudong, primary, Tzankov, Alexandar, primary, Fang, Xiaosheng, primary, Zhu, Feng, primary, Visco, Carlo, primary, Bhagat, Govind, primary, Dybkaer, Karen, primary, Chiu, April, primary, Tam, Wayne, primary, Zu, Youli, primary, Hsi, Eric D., primary, You, Hua, primary, Huh, Jooryung, primary, Ponzoni, Maurilio, primary, Ferreri, Andrés J.M., primary, Møller, Michael B., primary, Parsons, Benjamin M., primary, Hagemeister, Fredrick, primary, van Krieken, J. Han, primary, Piris, Miguel A., primary, Winter, Jane N., primary, Li, Yong, primary, Xu, Bing, primary, Liu, Phillip, primary, and Young, Ken H., primary

Published
2023
Full Text
View/download PDF

7. Supplementary Tables 1-5 and Supplementary Figures 1-8 from Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents

Author

Deng, Manman, primary, Xu-Monette, Zijun Y., primary, Pham, Lan V., primary, Wang, Xudong, primary, Tzankov, Alexandar, primary, Fang, Xiaosheng, primary, Zhu, Feng, primary, Visco, Carlo, primary, Bhagat, Govind, primary, Dybkaer, Karen, primary, Chiu, April, primary, Tam, Wayne, primary, Zu, Youli, primary, Hsi, Eric D., primary, You, Hua, primary, Huh, Jooryung, primary, Ponzoni, Maurilio, primary, Ferreri, Andrés J.M., primary, Møller, Michael B., primary, Parsons, Benjamin M., primary, Hagemeister, Fredrick, primary, van Krieken, J. Han, primary, Piris, Miguel A., primary, Winter, Jane N., primary, Li, Yong, primary, Xu, Bing, primary, Liu, Phillip, primary, and Young, Ken H., primary

Published
2023
Full Text
View/download PDF

8. Data from Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents

Author

Deng, Manman, primary, Xu-Monette, Zijun Y., primary, Pham, Lan V., primary, Wang, Xudong, primary, Tzankov, Alexandar, primary, Fang, Xiaosheng, primary, Zhu, Feng, primary, Visco, Carlo, primary, Bhagat, Govind, primary, Dybkaer, Karen, primary, Chiu, April, primary, Tam, Wayne, primary, Zu, Youli, primary, Hsi, Eric D., primary, You, Hua, primary, Huh, Jooryung, primary, Ponzoni, Maurilio, primary, Ferreri, Andrés J.M., primary, Møller, Michael B., primary, Parsons, Benjamin M., primary, Hagemeister, Fredrick, primary, van Krieken, J. Han, primary, Piris, Miguel A., primary, Winter, Jane N., primary, Li, Yong, primary, Xu, Bing, primary, Liu, Phillip, primary, and Young, Ken H., primary

Published
2023
Full Text
View/download PDF

9. Supplementary Figures 1-3 from Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

Author

Xu-Monette, Ziju Y., primary, Xiao, Min, primary, Au, Qingyan, primary, Padmanabhan, Raghav, primary, Xu, Bing, primary, Hoe, Nicholas, primary, Rodríguez-Perales, Sandra, primary, Torres-Ruiz, Raul, primary, Manyam, Ganiraju C., primary, Visco, Carlo, primary, Miao, Yi, primary, Tan, Xiaohong, primary, Zhang, Hongwei, primary, Tzankov, Alexandar, primary, Wang, Jing, primary, Dybkær, Karen, primary, Tam, Wayne, primary, You, Hua, primary, Bhagat, Govind, primary, Hsi, Eric D., primary, Ponzoni, Maurilio, primary, Ferreri, Andrés J.M., primary, Møller, Michael B., primary, Piris, Miguel A., primary, van Krieken, J. Han, primary, Winter, Jane N., primary, Westin, Jason R., primary, Pham, Lan V., primary, Medeiros, L. Jeffrey, primary, Rassidakis, George Z., primary, Li, Yong, primary, Freeman, Gordon J., primary, and Young, Ken H., primary

Published
2023
Full Text
View/download PDF

10. Supplementary Figures 1-3 from Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

Author

Xu-Monette, Ziju Y., primary, Xiao, Min, primary, Au, Qingyan, primary, Padmanabhan, Raghav, primary, Xu, Bing, primary, Hoe, Nicholas, primary, Rodríguez-Perales, Sandra, primary, Torres-Ruiz, Raul, primary, Manyam, Ganiraju C., primary, Visco, Carlo, primary, Miao, Yi, primary, Tan, Xiaohong, primary, Zhang, Hongwei, primary, Tzankov, Alexandar, primary, Wang, Jing, primary, Dybkær, Karen, primary, Tam, Wayne, primary, You, Hua, primary, Bhagat, Govind, primary, Hsi, Eric D., primary, Ponzoni, Maurilio, primary, Ferreri, Andrés J.M., primary, Møller, Michael B., primary, Piris, Miguel A., primary, van Krieken, J. Han, primary, Winter, Jane N., primary, Westin, Jason R., primary, Pham, Lan V., primary, Medeiros, L. Jeffrey, primary, Rassidakis, George Z., primary, Li, Yong, primary, Freeman, Gordon J., primary, and Young, Ken H., primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figure 1 from In Vitro and In Vivo Therapeutic Efficacy of Carfilzomib in Mantle Cell Lymphoma: Targeting the Immunoproteasome

Author

Zhang, Liang, primary, Pham, Lan V., primary, Newberry, Kate J., primary, Ou, Zhishuo, primary, Liang, Rong, primary, Qian, Jianfei, primary, Sun, Luhong, primary, Blonska, Marzenna, primary, You, Yun, primary, Yang, Jing, primary, Lin, Xin, primary, Rollo, Alex, primary, Tamayo, Archito T., primary, Lee, John, primary, Ford, Richard J., primary, Zhao, Xiurong, primary, Kwak, Larry W., primary, Yi, Qing, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

12. Data from Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

Author

Xu-Monette, Ziju Y., primary, Xiao, Min, primary, Au, Qingyan, primary, Padmanabhan, Raghav, primary, Xu, Bing, primary, Hoe, Nicholas, primary, Rodríguez-Perales, Sandra, primary, Torres-Ruiz, Raul, primary, Manyam, Ganiraju C., primary, Visco, Carlo, primary, Miao, Yi, primary, Tan, Xiaohong, primary, Zhang, Hongwei, primary, Tzankov, Alexandar, primary, Wang, Jing, primary, Dybkær, Karen, primary, Tam, Wayne, primary, You, Hua, primary, Bhagat, Govind, primary, Hsi, Eric D., primary, Ponzoni, Maurilio, primary, Ferreri, Andrés J.M., primary, Møller, Michael B., primary, Piris, Miguel A., primary, van Krieken, J. Han, primary, Winter, Jane N., primary, Westin, Jason R., primary, Pham, Lan V., primary, Medeiros, L. Jeffrey, primary, Rassidakis, George Z., primary, Li, Yong, primary, Freeman, Gordon J., primary, and Young, Ken H., primary

Published
2023
Full Text
View/download PDF

13. Data from In Vitro and In Vivo Therapeutic Efficacy of Carfilzomib in Mantle Cell Lymphoma: Targeting the Immunoproteasome

Author

Zhang, Liang, primary, Pham, Lan V., primary, Newberry, Kate J., primary, Ou, Zhishuo, primary, Liang, Rong, primary, Qian, Jianfei, primary, Sun, Luhong, primary, Blonska, Marzenna, primary, You, Yun, primary, Yang, Jing, primary, Lin, Xin, primary, Rollo, Alex, primary, Tamayo, Archito T., primary, Lee, John, primary, Ford, Richard J., primary, Zhao, Xiurong, primary, Kwak, Larry W., primary, Yi, Qing, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Tables from Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

Author

Xu-Monette, Ziju Y., primary, Xiao, Min, primary, Au, Qingyan, primary, Padmanabhan, Raghav, primary, Xu, Bing, primary, Hoe, Nicholas, primary, Rodríguez-Perales, Sandra, primary, Torres-Ruiz, Raul, primary, Manyam, Ganiraju C., primary, Visco, Carlo, primary, Miao, Yi, primary, Tan, Xiaohong, primary, Zhang, Hongwei, primary, Tzankov, Alexandar, primary, Wang, Jing, primary, Dybkær, Karen, primary, Tam, Wayne, primary, You, Hua, primary, Bhagat, Govind, primary, Hsi, Eric D., primary, Ponzoni, Maurilio, primary, Ferreri, Andrés J.M., primary, Møller, Michael B., primary, Piris, Miguel A., primary, van Krieken, J. Han, primary, Winter, Jane N., primary, Westin, Jason R., primary, Pham, Lan V., primary, Medeiros, L. Jeffrey, primary, Rassidakis, George Z., primary, Li, Yong, primary, Freeman, Gordon J., primary, and Young, Ken H., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Table 1 from In Vitro and In Vivo Therapeutic Efficacy of Carfilzomib in Mantle Cell Lymphoma: Targeting the Immunoproteasome

Author

Zhang, Liang, primary, Pham, Lan V., primary, Newberry, Kate J., primary, Ou, Zhishuo, primary, Liang, Rong, primary, Qian, Jianfei, primary, Sun, Luhong, primary, Blonska, Marzenna, primary, You, Yun, primary, Yang, Jing, primary, Lin, Xin, primary, Rollo, Alex, primary, Tamayo, Archito T., primary, Lee, John, primary, Ford, Richard J., primary, Zhao, Xiurong, primary, Kwak, Larry W., primary, Yi, Qing, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

16. Table S1 from Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas

Author

Pham, Lan V., primary, Huang, Shengjian, primary, Zhang, Hui, primary, Zhang, Jun, primary, Bell, Taylor, primary, Zhou, Shouhao, primary, Pogue, Elizabeth, primary, Ding, Zhiyong, primary, Lam, Laura, primary, Westin, Jason, primary, Davis, R. Eric, primary, Young, Ken H., primary, Medeiros, L. Jeffrey, primary, Ford, Richard J., primary, Nomie, Krystle, primary, Zhang, Leo, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

18. Figure S2 from Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas

Author

Pham, Lan V., primary, Huang, Shengjian, primary, Zhang, Hui, primary, Zhang, Jun, primary, Bell, Taylor, primary, Zhou, Shouhao, primary, Pogue, Elizabeth, primary, Ding, Zhiyong, primary, Lam, Laura, primary, Westin, Jason, primary, Davis, R. Eric, primary, Young, Ken H., primary, Medeiros, L. Jeffrey, primary, Ford, Richard J., primary, Nomie, Krystle, primary, Zhang, Leo, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

19. Figure S3 from Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas

Author

Pham, Lan V., primary, Huang, Shengjian, primary, Zhang, Hui, primary, Zhang, Jun, primary, Bell, Taylor, primary, Zhou, Shouhao, primary, Pogue, Elizabeth, primary, Ding, Zhiyong, primary, Lam, Laura, primary, Westin, Jason, primary, Davis, R. Eric, primary, Young, Ken H., primary, Medeiros, L. Jeffrey, primary, Ford, Richard J., primary, Nomie, Krystle, primary, Zhang, Leo, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

21. Figure S3 from Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas

Author

Pham, Lan V., primary, Huang, Shengjian, primary, Zhang, Hui, primary, Zhang, Jun, primary, Bell, Taylor, primary, Zhou, Shouhao, primary, Pogue, Elizabeth, primary, Ding, Zhiyong, primary, Lam, Laura, primary, Westin, Jason, primary, Davis, R. Eric, primary, Young, Ken H., primary, Medeiros, L. Jeffrey, primary, Ford, Richard J., primary, Nomie, Krystle, primary, Zhang, Leo, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

22. Figure S1 from Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas

Author

Pham, Lan V., primary, Huang, Shengjian, primary, Zhang, Hui, primary, Zhang, Jun, primary, Bell, Taylor, primary, Zhou, Shouhao, primary, Pogue, Elizabeth, primary, Ding, Zhiyong, primary, Lam, Laura, primary, Westin, Jason, primary, Davis, R. Eric, primary, Young, Ken H., primary, Medeiros, L. Jeffrey, primary, Ford, Richard J., primary, Nomie, Krystle, primary, Zhang, Leo, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

23. Figure S4 from Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas

Author

Pham, Lan V., primary, Huang, Shengjian, primary, Zhang, Hui, primary, Zhang, Jun, primary, Bell, Taylor, primary, Zhou, Shouhao, primary, Pogue, Elizabeth, primary, Ding, Zhiyong, primary, Lam, Laura, primary, Westin, Jason, primary, Davis, R. Eric, primary, Young, Ken H., primary, Medeiros, L. Jeffrey, primary, Ford, Richard J., primary, Nomie, Krystle, primary, Zhang, Leo, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

24. Table S1 from Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas

Author

Pham, Lan V., primary, Huang, Shengjian, primary, Zhang, Hui, primary, Zhang, Jun, primary, Bell, Taylor, primary, Zhou, Shouhao, primary, Pogue, Elizabeth, primary, Ding, Zhiyong, primary, Lam, Laura, primary, Westin, Jason, primary, Davis, R. Eric, primary, Young, Ken H., primary, Medeiros, L. Jeffrey, primary, Ford, Richard J., primary, Nomie, Krystle, primary, Zhang, Leo, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

25. Figure S4 from Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas

Author

Pham, Lan V., primary, Huang, Shengjian, primary, Zhang, Hui, primary, Zhang, Jun, primary, Bell, Taylor, primary, Zhou, Shouhao, primary, Pogue, Elizabeth, primary, Ding, Zhiyong, primary, Lam, Laura, primary, Westin, Jason, primary, Davis, R. Eric, primary, Young, Ken H., primary, Medeiros, L. Jeffrey, primary, Ford, Richard J., primary, Nomie, Krystle, primary, Zhang, Leo, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

26. Figure S1 from Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas

Author

Pham, Lan V., primary, Huang, Shengjian, primary, Zhang, Hui, primary, Zhang, Jun, primary, Bell, Taylor, primary, Zhou, Shouhao, primary, Pogue, Elizabeth, primary, Ding, Zhiyong, primary, Lam, Laura, primary, Westin, Jason, primary, Davis, R. Eric, primary, Young, Ken H., primary, Medeiros, L. Jeffrey, primary, Ford, Richard J., primary, Nomie, Krystle, primary, Zhang, Leo, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

27. Supplementary Figure Legends from Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas

Author

Pham, Lan V., primary, Huang, Shengjian, primary, Zhang, Hui, primary, Zhang, Jun, primary, Bell, Taylor, primary, Zhou, Shouhao, primary, Pogue, Elizabeth, primary, Ding, Zhiyong, primary, Lam, Laura, primary, Westin, Jason, primary, Davis, R. Eric, primary, Young, Ken H., primary, Medeiros, L. Jeffrey, primary, Ford, Richard J., primary, Nomie, Krystle, primary, Zhang, Leo, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

28. Figure S2 from Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas

Author

Pham, Lan V., primary, Huang, Shengjian, primary, Zhang, Hui, primary, Zhang, Jun, primary, Bell, Taylor, primary, Zhou, Shouhao, primary, Pogue, Elizabeth, primary, Ding, Zhiyong, primary, Lam, Laura, primary, Westin, Jason, primary, Davis, R. Eric, primary, Young, Ken H., primary, Medeiros, L. Jeffrey, primary, Ford, Richard J., primary, Nomie, Krystle, primary, Zhang, Leo, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

29. Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents

Author

Deng, Manman, primary, Xu-Monette, Zijun Y., additional, Pham, Lan V., additional, Wang, Xudong, additional, Tzankov, Alexandar, additional, Fang, Xiaosheng, additional, Zhu, Feng, additional, Visco, Carlo, additional, Bhagat, Govind, additional, Dybkaer, Karen, additional, Chiu, April, additional, Tam, Wayne, additional, Zu, Youli, additional, Hsi, Eric D., additional, You, Hua, additional, Huh, Jooryung, additional, Ponzoni, Maurilio, additional, Ferreri, Andrés J.M., additional, Møller, Michael B., additional, Parsons, Benjamin M., additional, Hagemeister, Fredrick, additional, van Krieken, J. Han, additional, Piris, Miguel A., additional, Winter, Jane N., additional, Li, Yong, additional, Xu, Bing, additional, Liu, Phillip, additional, and Young, Ken H., additional

Published
2021
Full Text
View/download PDF

30. Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

Author

Xu-Monette, Ziju Y., primary, Xiao, Min, additional, Au, Qingyan, additional, Padmanabhan, Raghav, additional, Xu, Bing, additional, Hoe, Nicholas, additional, Rodríguez-Perales, Sandra, additional, Torres-Ruiz, Raul, additional, Manyam, Ganiraju C., additional, Visco, Carlo, additional, Miao, Yi, additional, Tan, Xiaohong, additional, Zhang, Hongwei, additional, Tzankov, Alexandar, additional, Wang, Jing, additional, Dybkær, Karen, additional, Tam, Wayne, additional, You, Hua, additional, Bhagat, Govind, additional, Hsi, Eric D., additional, Ponzoni, Maurilio, additional, Ferreri, Andrés J.M., additional, Møller, Michael B., additional, Piris, Miguel A., additional, van Krieken, J. Han, additional, Winter, Jane N., additional, Westin, Jason R., additional, Pham, Lan V., additional, Medeiros, L. Jeffrey, additional, Rassidakis, George Z., additional, Li, Yong, additional, Freeman, Gordon J., additional, and Young, Ken H., additional

Published
2019
Full Text
View/download PDF

31. Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas

Author

Pham, Lan V., primary, Huang, Shengjian, additional, Zhang, Hui, additional, Zhang, Jun, additional, Bell, Taylor, additional, Zhou, Shouhao, additional, Pogue, Elizabeth, additional, Ding, Zhiyong, additional, Lam, Laura, additional, Westin, Jason, additional, Davis, R. Eric, additional, Young, Ken H., additional, Medeiros, L. Jeffrey, additional, Ford, Richard J., additional, Nomie, Krystle, additional, Zhang, Leo, additional, and Wang, Michael, additional

Published
2018
Full Text
View/download PDF

32. In Vitro and In Vivo Therapeutic Efficacy of Carfilzomib in Mantle Cell Lymphoma: Targeting the Immunoproteasome

Author

Zhang, Liang, primary, Pham, Lan V., additional, Newberry, Kate J., additional, Ou, Zhishuo, additional, Liang, Rong, additional, Qian, Jianfei, additional, Sun, Luhong, additional, Blonska, Marzenna, additional, You, Yun, additional, Yang, Jing, additional, Lin, Xin, additional, Rollo, Alex, additional, Tamayo, Archito T., additional, Lee, John, additional, Ford, Richard J., additional, Zhao, Xiurong, additional, Kwak, Larry W., additional, Yi, Qing, additional, and Wang, Michael, additional

Published
2013
Full Text
View/download PDF

33. Abstract 2432: The bruton's tyrosine kinase inhibitor ibrutinib synergized with the proteasome inhibitor carfilzomib and overcame immunoproteasome-mediated carfilzomib resistance in mantle cell lymphoma .

Author

Ou, Zhishuo, primary, Zhang, Liang, additional, Newberry, Kate, additional, Sun, Luhong, additional, Christopher, Kirk J., additional, Rollo, Alex, additional, Tamayo, Archito, additional, Lee, John, additional, Ford, Richard J., additional, Wang, Michael, additional, and Pham, Lan V., additional

Published
2013
Full Text
View/download PDF

34. Abstract 2854: Targeting constitutive NF-kB activation through Bruton's tyrosine kinase (Btk) and the proteasome in mantle cell lymphoma

Author

Ou, Zhishuo, primary, Tamayo, Archito T., additional, Zhang, Liang, additional, Lee, John, additional, Zhang, Kejie, additional, Li, Changping, additional, Wang, Jacqueline, additional, Pham, James, additional, Sun, Luhong, additional, Kirk, Christopher J., additional, Ford, Richard J., additional, and Pham, Lan V., additional

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results